Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Recurrent Low-Grade Ovarian Cancer Less Responsive to Chemotherapy
Link ID 4241
Title Recurrent Low-Grade Ovarian Cancer Less Responsive to Chemotherapy
Url http://www.medscape.com/viewarticle/571866?src=rss
Description Recurrent low-grade serous carcinoma of the ovary is more resistant to chemotherapy than the more common high-grade tumors. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Mar 25, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Individualizing Therapy for Renal Cell Carcinoma: Rationale, Clinical Considerations, and Challenges
  In this expert interview, Dr. Gary Hudes addresses prognostication and individualization of targeted and other therapies for patients with renal cell carcinoma as well as management of known and emerging toxicities. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


2. Smoking, Lung Cancer and Genetics: New Findings
  Dr. Eric Topol discusses recently published results of genome-wide association studies regarding the genetics of smoking addiction and lung cancer.
Category:   Articles > Hematology-Oncology


3. Adverse Event Reporting for Cancer Therapy Needs Revision
  The Common Terminology Criteria for Adverse Events was developed to standardize language for reporting adverse events that occur in NCI-sponsored clinical trials, but it is unable to adequately code the subacute adverse events that occur with new targeted therapies. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Question and Answer Session (Slides With Audio)
  Questions and answers for this paroxysmal nocturnal hemoglobinuria symposium: clinicians will better understand how to make a diagnosis, comprehend what is happening in patients, and advise treatment.
Category:   Articles > Hematology-Oncology


5. Treatment With VEGF Inhibitors May Cause Renal Thrombotic Microangiopathy
  VEGF inhibitors, such as bevacizumab, may cause glomerular disease that is characteristic of thrombotic microangiopathy. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS